-
Venezuela's Maduro back in US court after stunning capture
-
French court orders ex-bishop to pay over 1970s child sex abuse
-
PSG Ligue 1 game postponed in between two legs of Liverpool Champions League tie
-
Iran may believe it has the upper hand as Trump seeks talks
-
EU urged to broadly restrict 'forever chemicals'
-
Italy seizes millions 'embezzled' from Ursula Andress
-
Trump says Iran 'better get serious' in Mideast war talks
-
Global trading system hit by 'worst disruptions in the past 80 years': WTO chief
-
EU accuses four porn platforms of letting children access adult content
-
Cathay Pacific raises fuel surcharge on all flights by 34%
-
EU probes Snapchat over suspected child protection failings
-
EU parliament backs Trump tariff deal -- with conditions
-
'Return hubs' for migrants clear EU parliament hurdle
-
Meta watchdog says grassroots fact checks risk harm to users
-
G7 meets in France to mend transatlantic rupture on Iran
-
ByteDance quietly rolls out SeeDance 2.0 globally
-
Israel strikes Iran as Tehran rejects US talks overture
-
Mercedes teen ace Antonelli wants more of the same after maiden win
-
Singer Rosalia quits Milan concert with food poisoning
-
Oil climbs and equities sink amid mixed messages on 'talks'
-
'Get out': Verstappen bans reporter from Japan press conference
-
Leaked Nepal report into deadly uprising calls for prosecuting ex-PM
-
Verstappen says last-minute F1 rule tweak will help only 'a tiny bit'
-
Oil rises and equities mixed amid mixed messages on 'talks'
-
EU to vote on Trump tariff deal -- but eyes rest of world
-
Somalia football slowly becomes a women's game
-
Venezuela oil reserves both entice and repel energy giants
-
Hamilton says more committed to F1 than ever at 41
-
China bans runner after mid-marathon splits goes viral
-
Myanmar's rebuild stutters year after deadly quake
-
Murray's 53 points propel Nuggets over Mavs
-
Israel strikes Iran as Trump says Tehran wants deal to end war
-
Wilkinson calls for England to find consistency before World Cup
-
Norris talks up McLaren chances after double China disaster
-
Teen sprint star Gout Gout 'ready to rock and roll' in Melbourne
-
Hezbollah rejects truce talks as Israel presses Lebanon strikes
-
Mideast war fuels disinformation about Taiwan's gas supply
-
Kohli, Suryavanshi to light up IPL as stampede dead remembered
-
Moon race: how China is challenging the US
-
Zimbabwe lithium export ban triggers crackdown, concerns
-
Embiid, George make triumphant NBA returns in Sixers win
-
North Korea's Kim 'warmly' welcomes Belarusian leader
-
Oil edges up and equities mixed amid mixed messages on 'talks'
-
Russian oil arrives as Philippines battles 'energy emergency'
-
G7 meets in France to narrow transatlantic Iran split
-
WTO mulls future of global trade under cloud of Mideast war
-
McKellar tells Waratahs to 'roll sleeves up' against rivals Brumbies
-
Iran says 'no negotiations' as US warns to accept 15-point deal
-
Postecoglou 'not done yet' as he watches Spurs and Forest battle relegation
-
US activists work to connect Iranians via Starlink
US panel weighs authorizing Covid vaccines for youngest children
After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.
Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.
Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."
Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.
Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.
They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.
Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.
But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.
There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.
White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.
Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.
Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.
Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.
Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."
L.Durand--AMWN